What does CUSIP 03843E104 represent in this 13F holders report?

CUSIP 03843E104 is the security identifier for AQST - Aquestive Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AQST - Aquestive Therapeutics, Inc. - Common Stock in Q1 2024?

96 institutional investors reported AQST - Aquestive Therapeutics, Inc. - Common Stock for Q1 2024. Use the holders table for investor-level position and value details.

Aquestive Therapeutics, Inc. - Common Stock (AQST)

CUSIP: 03843E104

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock
Total 13F shares: 41,491,141
Total 13F value: $176,751,489
Share change: +18,293,972
Put/Call ratio: 95%
SEC-reported price per share: $4.26
Number of holders: 96
Value change: +$88,086,384
Number of buys: 73
Number of sells: 23
Shares outstanding: 124,885,109

Security key

03843E104

Report period

Q1 2024

Institutions

Top holders

AQST full security history Ownership snapshot Full 13F holder table Aquestive Therapeutics, Inc. SEC filings Aquestive Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AQST - Aquestive Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Bratton Capital Managemen...

Disclosed value leader

Bratton Capital Managemen...

Comparable rows

15/15

Latest evidence

31 Dec 2023

13F Lead comparable stake: 7.9% Showing 1-6 of 15 holder rows.

Quick read

Bratton Capital Management, L.P. leads the comparable SEC ownership view at 7.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bratton Capital Management, L.P.'s linked filing trail.

Comparable ownership Top 5

Bratton Capital Management, L.P. 7.9%

ARMISTICE CAPITAL, LLC 3.1%

VANGUARD GROUP INC 1.5%

RENAISSANCE TECHNOLOGIES LLC 1%

ESSEX INVESTMENT MANAGEMENT CO LLC 0.68%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bratton Capital Management, L.P.	13F Company 13F	7.9%	$19,818,135 9,810,958 shares	—	31 Dec 2023
ARMISTICE CAPITAL, LLC	13F Company 13F	3.1%	$7,926,480 3,924,000 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	1.5%	$3,815,887 1,889,053 shares	—	31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	1%	$2,568,000 1,271,500 shares	—	31 Dec 2023
ESSEX INVESTMENT MANAGEMENT CO LLC	13F Company 13F	0.68%	$1,709,257 846,167 shares	—	31 Dec 2023
Vahanian & Associates Financial Planning Inc.	13F Company 13F	0.47%	$1,195,048 591,608 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

41,491,141

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %